ARRDC1-AS1: A Potential Drug Target for Cancer, Obesity and Neurodegenerative Diseases

Target Name: ARRDC1-AS1

NCBI ID: G85026

ARRDC1-AS1

ARRDC1-AS1: A Potential Drug Target for Cancer, Obesity and Neurodegenerative Diseases

ARRDC1-AS1 (AD038) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the ARRDC1 gene family, which is known for its role in cell signaling and metabolism.

ARRDC1-AS1 has been identified as a potential drug target (or biomarker) due to its involvement in several disease processes, including cancer, obesity, and neurodegenerative diseases.

One of the key functions of ARRDC1-AS1 is its role in the regulation of cellular metabolism. It is a regulator of the GLUTAMYL-TRANSFERASIN (GTA) gene, which is involved in the transfer of amino acids from the cytosol to the endoplasmic reticulum. ARRDC1-AS1 has been shown to play a role in the regulation of GTA expression and function, which is important for the proper functioning of intracellular signaling pathways.

In addition to its role in cellular metabolism, ARRDC1-AS1 is also involved in the regulation of inflammation and immune responses. It is a co-regulator of the NF-kappa-B signaling pathway, which is involved in the regulation of inflammation and immune responses.

ARRDC1-AS1 has also been shown to be involved in the regulation of cell death and survival. It is a regulator of the Bcl-2 protein, which is involved in the regulation of cell death and survival.

In addition to its involvement in cellular metabolism, ARRDC1-AS1 is also involved in the regulation of gene expression and signaling pathways. It is a regulator of the AP-1/CREB-p21 signaling pathway, which is involved in the regulation of cellular growth and differentiation.

ARRDC1-AS1 is also involved in the regulation of protein synthesis and degradation. It is a regulator of the tyrosine kinase (TKG) gene, which is involved in the regulation of protein synthesis and degradation.

In conclusion, ARRDC1-AS1 is a protein that is involved in a number of important cellular processes that are important for the proper functioning of the body. Its involvement in the regulation of cellular metabolism, inflammation, immune responses, cell death and survival, and protein synthesis and degradation makes it a potential drug target (or biomarker) for a variety of diseases. Further research is needed to fully understand the role of ARRDC1-AS1 in these processes and to develop effective treatments for these diseases.

Protein Name: ARRDC1 Antisense RNA 1

The "ARRDC1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARRDC1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets